Newsroom

Displaying 41–50 of 135

February 20, 2025

Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025

February 13, 2025

Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

January 2, 2025

Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference

November 21, 2024

Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

November 8, 2024

Seer to Participate in Upcoming November Investor Conferences

November 6, 2024

Seer Reports Third Quarter 2024 Financial Results

November 6, 2024

Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific

October 31, 2024

Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024

October 21, 2024

Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024

October 17, 2024

Seer to Report Third Quarter 2024 Financial Results on November 6, 2024

Starting your proteomics research is effortless

Connect with an expert to discuss which path to the full proteome is right for you.

  1. Bring the Proteograph Product Suite in-house
  2. Run a project with
    Seer Technology
    Access Center
  3. Conduct a project with
    a Seer service provider
    or Center of Excellence